Organization
Rheumatology, Seligman Center for Advanced Therapeutics, New York, United States
1 abstract
Abstract
AN ESTIMATE OF THE PROPORTION OF PATIENTS WITH SLE RECEIVING OFF-LABEL TREATMENT WITH RITUXIMAB IN EUROPEAN COUNTRIES Org: Medicine, Karolinska Institute, Stockholm, Sweden, Rheumatology, Rigshospitalet, Copenhagen, Denmark, Medicine, Charite University Hospitals, Berlin, Germany, Divisions of Rheumatology and Internal Medicine, Catholic University of the Sacred Heart, Rome, Italy, Rheumatology, Catholic University of Louvain, Brussels, Belgium,